To create an Hep C cure that truly challenges treatment limitations—like DDIs, reduced efficacy in those taking PPIs, or inability to treat people with severe renal impairment—we looked deeply at patients. Through them, we understood why previous treatments had failed, and created one solution to treat almost everyone. Introducing EndGen: a cure versatile enough to treat the diverse patient types beyond each genotype.

To get people to take notice about EndGen, we created a 360  campaign that uses the "Terminator" target approach to call out a person's symptoms.